Michael S. Hearne, Officer, Chief Executive Officer, Chief Financial Officer, Chief Operating Officer at Odonate Therapeutics, Inc. (ODT), bought 30,000 shares at $15.77 ($466K) on 2018-12-12, disclosed to the SEC on 2018-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.25 | 5,450 | $83K | 17.8% |
| 2 | $15.25 | 5,450 | $83K | 17.8% |
| 3 | $15.65 | 4,550 | $71K | 15.3% |
| 4 | $15.65 | 4,550 | $71K | 15.3% |
| 5 | $15.77 | 10,000 | $158K | 33.8% |
| Total | $15.54 avg | 30,000 |
| $466K |
| 100% |
| Filing → |